Xiaobei Hu
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
-
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
Papers in
-
- Protein Degradation and Inhibitors 13
- Ubiquitin and proteasome pathways 8
- Histone Deacetylase Inhibitors Research 6
- DNA Repair Mechanisms 3
-
- Acute Myeloid Leukemia Research 5
- Multiple Myeloma Research and Treatments 5
- Co-authors
- Yubo Zhou (20 shared papers)Jia Li (17 shared papers)Jia Li (2 shared papers)Lei Xu (6 shared papers)Jingya Li (1 shared paper)Yanan Duan (1 shared paper)Hongcheng Shi (1 shared paper)Lina Zhang (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (9 papers)European Journal of Medicinal Chemistry (8 papers)Acta Pharmacologica Sinica (2 papers)Cancer Letters (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xiaobei Hu
27 papers receiving 494 citations
Peers
Comparison fields: 5 of 64
- Hematology 81
- Oncology 120
- Molecular Biology 269
- Geriatrics and Gerontology 11
- Physiology 65
Countries citing papers authored by Xiaobei Hu
This map shows the geographic impact of Xiaobei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobei Hu more than expected).
Fields of papers citing papers by Xiaobei Hu
This network shows the impact of papers produced by Xiaobei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobei Hu. The network helps show where Xiaobei Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobei Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 115 | |
| 2 | 2021 | 64 | |
| 3 | 2015 | 34 | |
| 4 | 2019 | 23 | |
| 5 | 2021 | 22 | |
| 6 | 2019 | 21 | |
| 7 | 2019 | 20 | |
| 8 | 2021 | 20 | |
| 9 | 2022 | 18 | |
| 10 | 2022 | 16 | |
| 11 | 2024 | 16 | |
| 12 | 2018 | 16 | |
| 13 | 2021 | 12 | |
| 14 | 2023 | 11 | |
| 15 | 2016 | 11 | |
| 16 | 2020 | 10 | |
| 17 | 2021 | 10 | |
| 18 | 2021 | 10 | |
| 19 | 2023 | 9 | |
| 20 | 2015 | 8 |
About Xiaobei Hu
Xiaobei Hu is a scholar working on Molecular Biology, Hematology, Oncology, Cell Biology and Pathology and Forensic Medicine, having authored 27 papers that have together received 498 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (13 papers), Ubiquitin and proteasome pathways (8 papers), Histone Deacetylase Inhibitors Research (6 papers), Acute Myeloid Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (5 papers), Peptidase Inhibition and Analysis (4 papers), DNA Repair Mechanisms (3 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Hematology (81 citations), Oncology (120 citations), Molecular Biology (269 citations), Geriatrics and Gerontology (11 citations) and Physiology (65 citations). Xiaobei Hu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yubo Zhou, Jia Li, Jia Li, Lei Xu, Jingya Li, Yanan Duan, Hongcheng Shi, Lina Zhang, Mingfeng Xia and Xin Gao. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Acta Pharmacologica Sinica, Cancer Letters and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.